Brexit may delay access to new medicines - Anderson
Sinn Féin MEP Martina Anderson has warned that patients in the north may have to wait longer for vital new medicines as a result of Brexit.
Martina Anderson said:
"Currently all new medicines and drugs to enter the healthcare system are regulated and approved by the European Medicines Agency, which is based in London.
"There is considerable doubt however, about what will happen if Britain leaves the European Medicines Agency as a result of Brexit.
"One outcome could be that patients have to wait longer for access to new medicines because we would no longer be part of the EU under the Tory Brexit agenda.
"That would potentially put people's health at risk.
"The best way to retain our membership of the European Medicines Agency is for the north to secure designated status within the EU."